Staples Versus Dermabond for Closure of the Skin After Cesarean Section
1 other identifier
interventional
50
1 country
1
Brief Summary
Two of the more frequently used options for skin closure following a cesarean delivery include staples or sutures (stitches). Another method of closure is Dermabond- liquid skin adhesive. This method of closure is used less frequently than either staples or sutures. Few studies have been done regarding whether Dermabond is preferable or affect the outcome of a cesarean section surgery. The aim of our study is to find weather Dermabond haas better result for the closure of cesarean section wounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2010
CompletedFirst Posted
Study publicly available on registry
December 16, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedDecember 16, 2010
October 1, 2010
1.1 years
December 6, 2010
December 15, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Cosmetic objective evaluation of the scar
6 weeks postoperatively
Secondary Outcomes (2)
The difference in pain between the two type of closure
1 and 4 days postoperatively
The difference in patient satisfaction with the scar result
6 weeks postoperatively
Study Arms (1)
Woman with previous ceasarean section - staples
ACTIVE COMPARATORInterventions
Dermabond- liquid skin adhesive
Eligibility Criteria
You may qualify if:
- Woman over 18 year Woman having elective caesarean section
You may not qualify if:
- Age under 18 Woman having an emergency caesarean section
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meir medical center
Kfar Saba, Israel
Study Officials
- PRINCIPAL INVESTIGATOR
Dana Sadeh, MD
MD
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 6, 2010
First Posted
December 16, 2010
Study Start
January 1, 2011
Primary Completion
February 1, 2012
Last Updated
December 16, 2010
Record last verified: 2010-10